Frankfurt - Delayed Quote EUR
Regulus Therapeutics Inc. (7RG0.F)
2.2800
+0.2600
+(12.87%)
As of 9:28:05 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-41,673
-41,673
-26,768
-25,526
-24,128
Investing Cash Flow
-35,983
-35,983
14,491
-15,120
-251
Financing Cash Flow
92,417
92,417
11,816
4,491
53,737
End Cash Position
38,590
38,590
23,829
24,290
60,445
Income Tax Paid Supplemental Data
1
1
1
1
1
Interest Paid Supplemental Data
66
66
447
491
729
Capital Expenditure
-340
-340
-613
-361
-251
Issuance of Capital Stock
93,860
93,860
15,120
4,491
53,791
Repayment of Debt
-1,377
-1,377
-3,304
--
-80
Repurchase of Capital Stock
-69
-69
--
--
--
Free Cash Flow
-42,013
-42,013
-27,381
-25,887
-24,379
12/31/2021 - 8/21/2013
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade